Apotex posts loss in first quarter after going public – CP24

Skip to main content

ADVERTISEMENT

The Open

Apotex posts loss in first quarter after going public

Evan Seigerman, managing director and head of healthcare research at BMO, joins BNN Bloomberg to discuss Apotex's earnings.

August 12, 2026 at 10:33a.m. EDT

Cameco keeps production guidance despite disruptionsOpens in new window

08:17 · July 31, 2026 at 11:10a.m. EDT

Mullen Group reports solid Q2 beatOpens in new window

05:43 · July 23, 2026 at 10:05a.m. EDT

Horizon Aircraft selling up to 100 aircraft in AustraliaOpens in new window

07:07 · July 21, 2026 at 10:51a.m. EDT

War-related costs pressures still working into prices, says Bank of CanadaOpens in new window

08:12 · July 15, 2026 at 10:54a.m. EDT

'Market right now has one rate hike priced into Canada this year, I would bet against that': DevlinOpens in new window

06:23 · July 15, 2026 at 10:05a.m. EDT

SK Hynix becomes the largest foreign listing in American historyOpens in new window

07:02 · July 10, 2026 at 11:29a.m. EDT

Could SpaceX governance structure set a precedent?Opens in new window

07:00 · June 12, 2026 at 10:55a.m. EDT

'At least a 10% pop would be necessary for it to be considered successful': Smith on SpaceXOpens in new window

06:08 · June 12, 2026 at 9:33a.m. EDT

Could SpaceX merge with Tesla?Opens in new window

06:39 · June 12, 2026 at 9:26a.m. EDT

'I think the data makes the case for a hold': Kronick on BoC rate decisionOpens in new window

06:30 · June 10, 2026 at 10:33a.m. EDT